These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. Groom GN; Junck L; Foster NL; Frey KA; Kuhl DE J Nucl Med; 1995 Dec; 36(12):2207-10. PubMed ID: 8523106 [TBL] [Abstract][Full Text] [Related]
25. Microglial activation in perinatal rabbit brain induced by intrauterine inflammation: detection with 11C-(R)-PK11195 and small-animal PET. Kannan S; Saadani-Makki F; Muzik O; Chakraborty P; Mangner TJ; Janisse J; Romero R; Chugani DC J Nucl Med; 2007 Jun; 48(6):946-54. PubMed ID: 17504871 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of reference tissue models for the analysis of [11C](R)-PK11195 studies. Kropholler MA; Boellaard R; Schuitemaker A; Folkersma H; van Berckel BN; Lammertsma AA J Cereb Blood Flow Metab; 2006 Nov; 26(11):1431-41. PubMed ID: 16511500 [TBL] [Abstract][Full Text] [Related]
27. [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Doorduin J; Klein HC; Dierckx RA; James M; Kassiou M; de Vries EF Mol Imaging Biol; 2009; 11(6):386-98. PubMed ID: 19330384 [TBL] [Abstract][Full Text] [Related]
28. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine. Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609 [TBL] [Abstract][Full Text] [Related]
29. In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors. Boutin H; Chauveau F; Thominiaux C; Kuhnast B; Grégoire MC; Jan S; Trebossen R; Dollé F; Tavitian B; Mattner F; Katsifis A Glia; 2007 Nov; 55(14):1459-68. PubMed ID: 17680643 [TBL] [Abstract][Full Text] [Related]
30. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies. Yaqub M; van Berckel BN; Schuitemaker A; Hinz R; Turkheimer FE; Tomasi G; Lammertsma AA; Boellaard R J Cereb Blood Flow Metab; 2012 Aug; 32(8):1600-8. PubMed ID: 22588187 [TBL] [Abstract][Full Text] [Related]
31. Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [(18)F]PBR102 and [ (18)F]PBR111 in a model of excitotoxin-induced neuroinflammation. Callaghan PD; Wimberley CA; Rahardjo GL; Berghofer PJ; Pham TQ; Jackson T; Zahra D; Bourdier T; Wyatt N; Greguric I; Howell NR; Siegele R; Pastuovic Z; Mattner F; Loc'h C; Gregoire MC; Katsifis A Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):138-51. PubMed ID: 25231248 [TBL] [Abstract][Full Text] [Related]
32. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? Bartels AL; Willemsen AT; Doorduin J; de Vries EF; Dierckx RA; Leenders KL Parkinsonism Relat Disord; 2010 Jan; 16(1):57-9. PubMed ID: 19487152 [TBL] [Abstract][Full Text] [Related]
33. Reference tissue models and blood-brain barrier disruption: lessons from (R)-[11C]PK11195 in traumatic brain injury. Folkersma H; Boellaard R; Vandertop WP; Kloet RW; Lubberink M; Lammertsma AA; van Berckel BN J Nucl Med; 2009 Dec; 50(12):1975-9. PubMed ID: 19910429 [TBL] [Abstract][Full Text] [Related]
34. 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke. Boutin H; Murray K; Pradillo J; Maroy R; Smigova A; Gerhard A; Jones PA; Trigg W Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):503-11. PubMed ID: 25351507 [TBL] [Abstract][Full Text] [Related]
35. Microglial activation in young adults with autism spectrum disorder. Suzuki K; Sugihara G; Ouchi Y; Nakamura K; Futatsubashi M; Takebayashi K; Yoshihara Y; Omata K; Matsumoto K; Tsuchiya KJ; Iwata Y; Tsujii M; Sugiyama T; Mori N JAMA Psychiatry; 2013 Jan; 70(1):49-58. PubMed ID: 23404112 [TBL] [Abstract][Full Text] [Related]
36. Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain. Pedersen MD; Minuzzi L; Wirenfeldt M; Meldgaard M; Slidsborg C; Cumming P; Finsen B Eur J Neurosci; 2006 Aug; 24(4):991-1000. PubMed ID: 16930426 [TBL] [Abstract][Full Text] [Related]
37. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure. Kannan S; Saadani-Makki F; Balakrishnan B; Chakraborty P; Janisse J; Lu X; Muzik O; Romero R; Chugani DC Dev Neurosci; 2011; 33(3-4):231-40. PubMed ID: 21791891 [TBL] [Abstract][Full Text] [Related]
38. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue. Ni R; Röjdner J; Voytenko L; Dyrks T; Thiele A; Marutle A; Nordberg A J Alzheimers Dis; 2021; 80(4):1723-1737. PubMed ID: 33749648 [TBL] [Abstract][Full Text] [Related]
39. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. Vas A; Shchukin Y; Karrenbauer VD; Cselényi Z; Kostulas K; Hillert J; Savic I; Takano A; Halldin C; Gulyás B J Neurol Sci; 2008 Jan; 264(1-2):9-17. PubMed ID: 17727889 [TBL] [Abstract][Full Text] [Related]